Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

InMed Pharmaceuticals - 12 Year Stock Price History | INM

Historical daily share price chart and data for InMed Pharmaceuticals since 2013 adjusted for splits and dividends. The latest closing stock price for InMed Pharmaceuticals as of July 25, 2025 is 2.64.
  • The all-time high InMed Pharmaceuticals stock closing price was 31181.90 on January 03, 2018.
  • The InMed Pharmaceuticals 52-week high stock price is 15.70, which is 494.7% above the current share price.
  • The InMed Pharmaceuticals 52-week low stock price is 1.72, which is 34.8% below the current share price.
  • The average InMed Pharmaceuticals stock price for the last 52 weeks is 3.85.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
InMed Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.0169 4.8000 5.0500 1.8600 2.6400 -44.30%
2024 5.7297 7.8000 8.8000 2.4520 4.7400 -43.03%
2023 21.0710 44.2000 46.0000 6.5980 8.3200 -79.41%
2022 288.1619 680.0000 680.0000 26.4000 40.4000 -93.83%
2021 1405.4002 1745.0000 2675.0000 655.0000 655.0000 -60.18%
2020 2681.0262 3134.6900 4850.5200 1487.5000 1645.0000 -44.61%
2019 4910.4757 4779.5700 9849.5200 2887.2100 2969.7000 -29.40%
2018 12077.9427 23630.6000 31181.9000 3792.9700 4206.1100 -76.05%
2017 6163.9259 2969.7000 17564.2000 2889.3600 17564.2000 526.24%
2016 1631.8703 1913.8100 3233.6800 824.9170 2804.7200 47.83%
2015 2652.4540 1979.8000 5058.3900 1443.6100 1897.3100 -4.17%
2014 4520.4915 4388.5600 10525.9000 1656.4400 1979.8000 344.44%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.005B
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $79.478B 30.57
Zoetis (ZTS) United States $68.037B 25.39
Daiichi Sankyo, - (DSNKY) Japan $46.885B 24.03
Takeda Pharmaceutical (TAK) Japan $46.647B 9.28
BeOne Medicines - (ONC) Cayman Islands $32.492B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.501B 0.00
Summit Therapeutics (SMMT) United States $20.475B 0.00
Merck (MKKGY) Germany $17.325B 12.69
Shionogi (SGIOY) Japan $14.589B 14.62
United Therapeutics (UTHR) United States $13.821B 12.23
Neurocrine Biosciences (NBIX) United States $13.028B 44.62
Orion OYJ (ORINY) Finland $11.714B 28.23
IPSEN (IPSEY) France $11.064B 0.00
Stevanato Group S.p.A (STVN) Italy $8.464B 51.76
Corcept Therapeutics (CORT) United States $7.168B 58.27
Grifols, S.A (GRFS) Spain $6.834B 0.00
Ionis Pharmaceuticals (IONS) United States $6.709B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.643B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.204B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.436B 0.00
Hypermarcas (HYPMY) Brazil $3.085B 20.29
Crinetics Pharmaceuticals (CRNX) United States $2.847B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.626B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.564B 8.98
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.507B 13.56
Centessa Pharmaceuticals (CNTA) United Kingdom $2.067B 0.00
Ocular Therapeutix (OCUL) United States $1.899B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.789B 0.00
ARS Pharmaceuticals (SPRY) United States $1.760B 0.00
Endo (NDOI) United States $1.755B 0.00
Evotec AG (EVO) Germany $1.438B 0.00
Harrow (HROW) United States $1.366B 0.00
Guardian Pharmacy Services (GRDN) United States $1.283B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.225B 24.51
Avadel Pharmaceuticals (AVDL) Ireland $1.088B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Dyne Therapeutics (DYN) United States $1.050B 0.00
Ardelyx (ARDX) United States $1.043B 0.00
Collegium Pharmaceutical (COLL) United States $1.032B 5.57
Akebia Therapeutics (AKBA) United States $1.009B 0.00
Verve Therapeutics (VERV) United States $0.992B 0.00
ProKidney (PROK) United States $0.954B 0.00
Xeris Biopharma Holdings (XERS) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
KalVista Pharmaceuticals (KALV) United States $0.779B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.740B 0.00
Xencor (XNCR) United States $0.658B 0.00
Zevra Therapeutics (ZVRA) United States $0.638B 0.00
Relay Therapeutics (RLAY) United States $0.631B 0.00
Organogenesis (ORGO) United States $0.603B 0.00
USANA Health Sciences (USNA) United States $0.598B 12.02
Elite Pharmaceuticals (ELTP) United States $0.580B 0.00
Theravance Biopharma (TBPH) United States $0.557B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Bioventus (BVS) United States $0.526B 13.33
Siga Technologies (SIGA) United States $0.504B 10.54
Tourmaline Bio (TRML) United States $0.482B 0.00
Savara (SVRA) United States $0.441B 0.00
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.365B 9.87
AleAnna (ANNA) United States $0.357B 0.00
Altimmune (ALT) United States $0.333B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.326B 0.00
Nanobiotix S.A (NBTX) France $0.306B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Esperion Therapeutics (ESPR) United States $0.295B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.275B 25.20
OmniAb (OABI) United States $0.259B 0.00
Larimar Therapeutics (LRMR) United States $0.240B 0.00
MediWound (MDWD) Israel $0.225B 0.00
Liminatus Pharma (LIMN) United States $0.220B 0.00
4D Molecular Therapeutics (FDMT) United States $0.214B 0.00
China SXT Pharmaceuticals (SXTC) China $0.188B 0.00
Galectin Therapeutics (GALT) United States $0.186B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Journey Medical (DERM) United States $0.179B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lyell Immunopharma (LYEL) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.133B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Lexeo Therapeutics (LXEO) United States $0.122B 0.00
Cassava Sciences (SAVA) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Nutriband (NTRB) United States $0.098B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
Metagenomi (MGX) United States $0.094B 0.00
Achieve Life Sciences (ACHV) Canada $0.094B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Champions Oncology (CSBR) United States $0.092B 20.78
ESSA Pharma (EPIX) Canada $0.083B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Inotiv (NOTV) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Surrozen (SRZN) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Rafael Holdings (RFL) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Wellgistics Health (WGRX) United States $0.068B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Klotho Neurosciences (KLTO) United States $0.058B 0.00
Century Therapeutics (IPSC) United States $0.057B 0.00
ElectroCore (ECOR) United States $0.056B 0.00
Jupiter Neurosciences (JUNS) United States $0.055B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 37.33
Incannex Healthcare (IXHL) Australia $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.036B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 2.65
BioVie (BIVI) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00